ANI Pharma Inc Uncategorized Contracts & Agreements
24 Contracts & Agreements
- Contingent Value Rights Agreement dated September (Filed With SEC on September 20, 2024)
- Form of Capped Call Transaction Confirmation (Filed With SEC on August 13, 2024)
- Certain information has been excluded from this agreement (indicated by [***]) because such information is both not material and the type that the registrant treats as private or... (Filed With SEC on March 15, 2022)
- Form of Option Agreement (Filed With SEC on March 11, 2021)
- Description of Securities (Filed With SEC on March 11, 2021)
- ANI PHARMACEUTICALS, INC., ANIP ACQUISITION COMPANY, as Borrowers and ANIP PARTNER, LLC, AP EUROPEAN HOLDINGS, LLC, ANIP CO-OP, LLC, as Guarantors (Filed With SEC on August 4, 2016)
- 210 Main Street West, Baudette, MN 56623 Phone ###-###-#### Fax ###-###-#### Toll-Free ###-###-#### (Filed With SEC on April 27, 2016)
- [Signature Pageto Additional Bond Hedge Confirmation] (Filed With SEC on December 10, 2014)
- [Signature Page to Base Bond Hedge Confirmation] (Filed With SEC on December 8, 2014)
- Confidential Materials Omitted and FiledSeparately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under theSecurities... (Filed With SEC on November 10, 2014)
- FORM OF AMENDED AND RESTATED LOCK-UP AGREEMENT (Filed With SEC on April 12, 2013)
- FORM OF AMENDED AND RESTATED LOCK-UP AGREEMENT (Filed With SEC on April 12, 2013)
- ANIP ACQUISITION COMPANY As of October 3, 2012 (Filed With SEC on December 11, 2012)
- ANIP ACQUISITION COMPANY As of October 3, 2012 (Filed With SEC on December 11, 2012)
- [Logo of ANI Pharmaceuticals] (Filed With SEC on December 11, 2012)
- [Logo of ANI Pharmaceuticals] (Filed With SEC on December 11, 2012)
- FORM OF LOCK-UP AGREEMENT (Filed With SEC on October 4, 2012)
- [Remainder of page intentionally left blank] (Filed With SEC on August 17, 2012)
- [Remainder of page intentionally left blank] (Filed With SEC on March 4, 2011)
- [Remainder of page intentionally left blank] (Filed With SEC on August 14, 2009)
- [BIOSANTE LETTERHEAD] (Filed With SEC on August 7, 2009)
- FORM OFVOTING AGREEMENT (Filed With SEC on June 30, 2009)
- BIOSANTEPHARMACEUTICALS, INC. DESCRIPTIONOF NON-EMPLOYEE DIRECTOR COMPENSATIONARRANGEMENTS (Filed With SEC on March 16, 2009)
- Exclusive Sublicense Agreement dated as of November 7, 2006 between BioSante and Bradley Pharmaceuticals, Inc (Filed With SEC on March 27, 2007)
